The effect of topical diclofenac 3% and calcitriol 3 μg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): A phase II, randomized controlled trial.

Brinkhuizen, Tjinta

The effect of topical diclofenac 3% and calcitriol 3 μg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): A phase II, randomized controlled trial. [electronic resource] - Journal of the American Academy of Dermatology Jul 2016 - 126-34 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial

1097-6787

10.1016/j.jaad.2016.01.050 doi


Administration, Topical
Aged
Anti-Inflammatory Agents, Non-Steroidal--administration & dosage
Apoptosis--drug effects
Calcitriol--administration & dosage
Carcinoma, Basal Cell--chemistry
Cell Proliferation--drug effects
Diclofenac--administration & dosage
Drug Therapy, Combination
Female
Gels
Humans
Ki-67 Antigen--analysis
Male
Medication Adherence
Middle Aged
Ointments
Proto-Oncogene Proteins c-bcl-2--analysis
Single-Blind Method
Skin Neoplasms--chemistry
Treatment Outcome
Vitamins--administration & dosage